E-cadherin/alpha 6 integrin complex modulators (APAvadis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameE-cadherin/alpha 6 integrin complex modulators (APAvadis)
Drug Alias NameMETA binding peptides (APAvadis)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCadherin-1 modulatorsIntegrin Subunit Alpha 6 modulators
TargetsCadherin-1Integrin Subunit Alpha 6
Therapy Area/IndicationsEndometriosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAPAvadis Biotechnologies srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAPAvadis Biotechnologies srl
Active IndicationsN/A
Inactive IndicationsEndometriosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A